OncoGuide PlasmaSeq Oncopanel System
Plasma ctDNA targeted sequencing assay for RAS and BRAF V600E alterations used to support treatment selection in colorectal cancer in Japan.
- Developer
- Sysmex Corporation
- Intended use
- Other
- Cancer scope
- Colorectal cancer
- Specimen
- Plasma
- Molecular modality
- DNA mutation
- Current version
- Current OncoGuide PlasmaSeq Oncopanel System configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.